2.18
-0.09 (-3.96%)
-0.09 (-3.96%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 542,857 |
|
|||||
| News | - | ||||||
| Day High | 2.24 | Low High |
|||||
| Day Low | 2.14 | ||||||
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Infinity Pharmaceuticals Inc | INFI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.09 | -3.96% | 2.18 | 17:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.19 | 2.14 | 2.24 | 2.18 | 2.27 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,179 | 542,857 | $ 2.18 | $ 1,183,364 | - | 1.48 - 5.98 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:21:43 | 3 | $ 2.18 | USD |
Period:
Draw Mode:
Infinity Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 194.05M | 89.02M | 87.10M | $ 1.72M | $ - | -0.68 | -4.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 360.00k | 3.80% |
Infinity Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INFI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.28 | 2.37 | 2.11 | 2.25 | 1,102,959 | -0.10 | -4.39% |
| 1 Month | 2.55 | 2.783 | 2.11 | 2.48 | 1,139,982 | -0.37 | -14.51% |
| 3 Months | 3.82 | 3.87 | 2.11 | 3.01 | 1,583,608 | -1.64 | -42.93% |
| 6 Months | 2.99 | 3.89 | 1.48 | 2.75 | 4,475,772 | -0.81 | -27.09% |
| 1 Year | 1.81 | 5.98 | 1.48 | 3.07 | 3,560,776 | 0.37 | 20.44% |
| 3 Years | 1.40 | 5.98 | 0.60 | 2.81 | 1,371,537 | 0.78 | 55.71% |
| 5 Years | 1.21 | 5.98 | 0.60 | 2.64 | 1,210,294 | 0.97 | 80.17% |
Infinity Pharmaceuticals Description
| Infinity Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel medicines for the treatment of specific cancers. The company's developed products and those under development include therapies targeting hematologic malignancies, or blood cancers; refractory indolent non-Hodgkin lymphoma; refractory chronic lymphocytic leukemia; and solid tumors, including melanoma and non-small cell lung cancer. Infinity has a strategic partnership with AbbVie to develop some of its oncology-related treatments. The company operates in only one segment which is drug development. |
